US Stock MarketDetailed Quotes

BBIO BridgeBio Pharma

Watchlist
  • 25.310
  • +0.420+1.69%
Close Aug 23 16:00 ET
  • 25.310
  • 0.0000.00%
Post 20:01 ET
4.76BMarket Cap-9587P/E (TTM)

About BridgeBio Pharma Company

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

Company Profile

SymbolBBIO
Company NameBridgeBio Pharma
Listing DateJun 27, 2019
Issue Price17.00
Founded2015
CEODr. Neil Kumar, PhD
MarketNASDAQ
Employees556
Fiscal Year Ends12-31
Address3160 Porter Drive,Suite 250
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94304
Phone1-650-391-9740
Websitehttp://www.bridgebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Neil Kumar, PhD
  • Director and Chief Executive Officer of the Company and Eidos Therapeutics, Inc.
  • 12.16M
  • Dr. Brian C. Stephenson, PhD
  • Secretary, Chief Financial Officer and Principal Accounting Officer
  • 6.65M
  • Dr. Thomas Trimarchi, PhD
  • President and Chief Operating Officer
  • --
  • Dr. Charles J. Homcy,M.D.
  • Lead Independent Director and Chairman of Pharmaceuticals
  • 1.11M
  • Dr. Richard H. Scheller, PhD
  • Chairman of Research & Development
  • 2.01M
  • Dr. Frank P. McCormick, D.Sc.
  • Director
  • 1.74M
  • Ronald J. Daniels
  • Independent Director
  • 600.00K
  • Ali J. Satvat
  • Independent Director
  • 600.00K
  • Dr. Andrew W. Lo
  • Independent Director
  • 600.00K
  • Dr. Randal W. Scott,PhD
  • Independent Director
  • 600.00K
  • Dr. Hannah A. Valantine, M.D.
  • Independent Director
  • 600.00K
  • Jennifer E. Cook
  • Independent Director
  • 600.00K
  • Andrea John Ellis
  • Independent Director
  • 600.00K
  • Fred Hassan
  • Independent Director
  • 600.00K
  • Douglas A. Dachille
  • Independent Director
  • 600.00K
  • James C. Momtazee
  • Independent Director
  • 600.00K
  • Dr. Eric Aguiar, M.D.
  • Independent Director
  • 600.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg